Decode, detect, & defy: Expectations for digital biomarkers

In the past, the idea that technology could offer earlier detection and prevention of diseases, unparalleled insights into diseases currently not tracked well with diagnostic tests, and improved patient engagement, safety and quality of care, would have been laughable.\r\nOn the face of it, digital biomarkers are the holy grail, beautifully blurring the patient-consumer boundary, and providing clinicians with previously inconceivable levels of monitoring and data, and patients a level of health autonomy never previously possible.\r\nBut there is no perfect fit. Lack of precision, gaps in both evidence requirements and economic models, and questions around data ownership abound. Can digital biomarkers rise up to the expectations?